160 related articles for article (PubMed ID: 18618086)
1. Novel N-terminal cleavage of APP precludes Abeta generation in ACAT-defective AC29 cells.
Huttunen HJ; Puglielli L; Ellis BC; MacKenzie Ingano LA; Kovacs DM
J Mol Neurosci; 2009 Jan; 37(1):6-15. PubMed ID: 18618086
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway.
Huttunen HJ; Peach C; Bhattacharyya R; Barren C; Pettingell W; Hutter-Paier B; Windisch M; Berezovska O; Kovacs DM
FASEB J; 2009 Nov; 23(11):3819-28. PubMed ID: 19625658
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of ACAT-1 reduces amyloidogenic processing of APP.
Huttunen HJ; Greco C; Kovacs DM
FEBS Lett; 2007 Apr; 581(8):1688-92. PubMed ID: 17412327
[TBL] [Abstract][Full Text] [Related]
4. Role of acyl-coenzyme a: cholesterol acyltransferase activity in the processing of the amyloid precursor protein.
Puglielli L; Ellis BC; Ingano LA; Kovacs DM
J Mol Neurosci; 2004; 24(1):93-6. PubMed ID: 15314256
[TBL] [Abstract][Full Text] [Related]
5. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide.
Puglielli L; Konopka G; Pack-Chung E; Ingano LA; Berezovska O; Hyman BT; Chang TY; Tanzi RE; Kovacs DM
Nat Cell Biol; 2001 Oct; 3(10):905-12. PubMed ID: 11584272
[TBL] [Abstract][Full Text] [Related]
6. ACAT as a drug target for Alzheimer's disease.
Huttunen HJ; Kovacs DM
Neurodegener Dis; 2008; 5(3-4):212-4. PubMed ID: 18322393
[TBL] [Abstract][Full Text] [Related]
7. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
[TBL] [Abstract][Full Text] [Related]
8. Low-Density Lipoprotein Receptor-Related Protein-1 (LRP1) C4408R Mutant Promotes Amyloid Precursor Protein (APP) α-Cleavage in Vitro.
Hou H; Habib A; Zi D; Tian K; Tian J; Giunta B; Sawmiller D; Tan J
Neuromolecular Med; 2017 Sep; 19(2-3):300-308. PubMed ID: 28612181
[TBL] [Abstract][Full Text] [Related]
9. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
Kimura A; Hata S; Suzuki T
J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
[TBL] [Abstract][Full Text] [Related]
10. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.
Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S
Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932
[TBL] [Abstract][Full Text] [Related]
11. ACAT inhibition and amyloid beta reduction.
Bhattacharyya R; Kovacs DM
Biochim Biophys Acta; 2010 Aug; 1801(8):960-5. PubMed ID: 20398792
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism.
Tomita S; Kirino Y; Suzuki T
J Biol Chem; 1998 Mar; 273(11):6277-84. PubMed ID: 9497354
[TBL] [Abstract][Full Text] [Related]
13. Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes.
Fong LK; Yang MM; Dos Santos Chaves R; Reyna SM; Langness VF; Woodruff G; Roberts EA; Young JE; Goldstein LSB
J Biol Chem; 2018 Jul; 293(29):11341-11357. PubMed ID: 29858247
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
15. Elevated cellular cholesterol in Familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of β-amyloid precursor protein.
Cho YY; Kwon OH; Park MK; Kim TW; Chung S
PLoS One; 2019; 14(1):e0210535. PubMed ID: 30682043
[TBL] [Abstract][Full Text] [Related]
16. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease.
Hutter-Paier B; Huttunen HJ; Puglielli L; Eckman CB; Kim DY; Hofmeister A; Moir RD; Domnitz SB; Frosch MP; Windisch M; Kovacs DM
Neuron; 2004 Oct; 44(2):227-38. PubMed ID: 15473963
[TBL] [Abstract][Full Text] [Related]
17. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
[TBL] [Abstract][Full Text] [Related]
18. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
[TBL] [Abstract][Full Text] [Related]
19. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
20. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production.
Grbovic OM; Mathews PM; Jiang Y; Schmidt SD; Dinakar R; Summers-Terio NB; Ceresa BP; Nixon RA; Cataldo AM
J Biol Chem; 2003 Aug; 278(33):31261-8. PubMed ID: 12761223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
